Search results
Why Earnings Season Could Be Great for POINT Biopharma (PNT)
Zacks via Yahoo Finance· 1 year agoPOINT Biopharma PNT is seeing favorable earnings estimate revision activity and has a positive Zacks...
Wall Street Analysts Think POINT Biopharma Global Inc. (PNT) Could Surge 235%: Read This Before...
Zacks via Yahoo Finance· 2 years agoThe consensus price target hints at a 235.3% upside potential for POINT Biopharma Global Inc. (PNT)....
POINT Biopharma Global Inc. (NASDAQ:PNT) has caught the attention of institutional investors who...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in POINT Biopharma Global Inc. (NASDAQ:PNT) should be aware of the most powerful...
With 50% institutional ownership, POINT Biopharma Global Inc. (NASDAQ:PNT) is a favorite amongst the...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Institutions' substantial holdings in POINT Biopharma Global implies that they have...
What Should the Future of the Pacific Northwest Trail Look Like? The Forest Service Wants to Hear...
Backpacker via Yahoo News· 1 year agoThe United States Forest Service is asking community members for comments on the management of the...
POINT Biopharma Global Inc. (NASDAQ:PNT) Analysts Are More Bearish Than They Used To Be
Simply Wall St. via Yahoo Finance· 9 months agoToday is shaping up negative for POINT Biopharma Global Inc. (NASDAQ:PNT) shareholders, with the...
Calculating The Intrinsic Value Of POINT Biopharma Global Inc. (NASDAQ:PNT)
Simply Wall St. via Yahoo Finance· 2 years agoIn this article we are going to estimate the intrinsic value of POINT Biopharma Global Inc....
Institutional investors own a significant stake of 49% in POINT Biopharma Global Inc. (NASDAQ:PNT)
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Given the large stake in the stock by institutions, POINT Biopharma Global's stock...
Why Eli Lilly's $1.4 Billion Takeover Is A Boon For More Than Just Point Biopharma
Investor's Business Daily· 7 months agoEli Lilly said Tuesday it will buy cancer specialist Point Biopharma Global for $1.4 billion,...
Will Weakness in POINT Biopharma Global Inc.'s (NASDAQ:PNT) Stock Prove Temporary Given Strong...
Simply Wall St. via Yahoo Finance· 7 months agoIt is hard to get excited after looking at POINT Biopharma Global's (NASDAQ:PNT) recent performance,...